These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26621101)

  • 1. Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
    Pratt VM; Everts RE; Aggarwal P; Beyer BN; Broeckel U; Epstein-Baak R; Hujsak P; Kornreich R; Liao J; Lorier R; Scott SA; Smith CH; Toji LH; Turner A; Kalman LV
    J Mol Diagn; 2016 Jan; 18(1):109-23. PubMed ID: 26621101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.
    Pratt VM; Zehnbauer B; Wilson JA; Baak R; Babic N; Bettinotti M; Buller A; Butz K; Campbell M; Civalier C; El-Badry A; Farkas DH; Lyon E; Mandal S; McKinney J; Muralidharan K; Noll L; Sander T; Shabbeer J; Smith C; Telatar M; Toji L; Vairavan A; Vance C; Weck KE; Wu AH; Yeo KT; Zeller M; Kalman L
    J Mol Diagn; 2010 Nov; 12(6):835-46. PubMed ID: 20889555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative Project.
    Pratt VM; Turner A; Broeckel U; Dawson DB; Gaedigk A; Lynnes TC; Medeiros EB; Moyer AM; Requesens D; Vetrini F; Kalman LV
    J Mol Diagn; 2021 Aug; 23(8):952-958. PubMed ID: 34020041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project.
    Gaedigk A; Turner A; Everts RE; Scott SA; Aggarwal P; Broeckel U; McMillin GA; Melis R; Boone EC; Pratt VM; Kalman LV
    J Mol Diagn; 2019 Nov; 21(6):1034-1052. PubMed ID: 31401124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Reference Materials for CYP3A4 and CYP3A5: A (GeT-RM) Collaborative Project.
    Gaedigk A; Boone EC; Turner AJ; van Schaik RHN; Chernova D; Wang WY; Broeckel U; Granfield CA; Hodge JC; Ly RC; Lynnes TC; Mitchell MW; Moyer AM; Oliva J; Kalman LV
    J Mol Diagn; 2023 Sep; 25(9):655-664. PubMed ID: 37354993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Reference Materials for TPMT and NUDT15: A GeT-RM Collaborative Project.
    Pratt VM; Wang WY; Boone EC; Broeckel U; Cody N; Edelmann L; Gaedigk A; Lynnes TC; Medeiros EB; Moyer AM; Mitchell MW; Scott SA; Starostik P; Turner A; Kalman LV
    J Mol Diagn; 2022 Oct; 24(10):1079-1088. PubMed ID: 35931342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Reference Materials for DPYD: A GeT-RM Collaborative Project.
    Gaedigk A; Turner AJ; Moyer AM; Zubiaur P; Boone EC; Wang WY; Broeckel U; Kalman LV
    J Mol Diagn; 2024 Oct; 26(10):864-875. PubMed ID: 39032822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype and phenotype concordance for pharmacogenetic tests through proficiency survey testing.
    Wu AH
    Arch Pathol Lab Med; 2013 Sep; 137(9):1232-6. PubMed ID: 23991737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
    Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
    Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of pharmacogenetics to pharmacovigilance.
    Bondon-Guitton E; Despas F; Becquemont L
    Therapie; 2016 Apr; 71(2):223-8. PubMed ID: 27080842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project.
    Gaedigk A; Boone EC; Scherer SE; Lee SB; Numanagić I; Sahinalp C; Smith JD; McGee S; Radhakrishnan A; Qin X; Wang WY; Farrow EG; Gonzaludo N; Halpern AL; Nickerson DA; Miller NA; Pratt VM; Kalman LV
    J Mol Diagn; 2022 Apr; 24(4):337-350. PubMed ID: 35134542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?
    Lopes JL; Harris K; Karow MB; Peterson SE; Kluge ML; Kotzer KE; Lopes GS; Larson NB; Bielinski SJ; Scherer SE; Wang L; Weinshilboum RM; Black JL; Moyer AM
    J Mol Diagn; 2022 Mar; 24(3):253-261. PubMed ID: 35041929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Analytical Validation of a 29 Gene Clinical Pharmacogenetic Genotyping Panel: Multi-Ethnic Allele and Copy Number Variant Detection.
    Scott SA; Scott ER; Seki Y; Chen AJ; Wallsten R; Owusu Obeng A; Botton MR; Cody N; Shi H; Zhao G; Brake P; Nicoletti P; Yang Y; Delio M; Shi L; Kornreich R; Schadt EE; Edelmann L
    Clin Transl Sci; 2021 Jan; 14(1):204-213. PubMed ID: 32931151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational pharmacogenotype extraction from clinical next-generation sequencing.
    Shugg T; Ly RC; Osei W; Rowe EJ; Granfield CA; Lynnes TC; Medeiros EB; Hodge JC; Breman AM; Schneider BP; Sahinalp SC; Numanagić I; Salisbury BA; Bray SM; Ratcliff R; Skaar TC
    Front Oncol; 2023; 13():1199741. PubMed ID: 37469403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes.
    Twesigomwe D; Drögemöller BI; Wright GEB; Siddiqui A; da Rocha J; Lombard Z; Hazelhurst S
    Clin Pharmacol Ther; 2021 Sep; 110(3):741-749. PubMed ID: 33492672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of simplified and rapid detection assay for genetic polymorphisms influencing drug response and its clinical applications].
    Hiratsuka M
    Yakugaku Zasshi; 2002 Jul; 122(7):451-63. PubMed ID: 12136641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance of DMET plus genotyping results with those of orthogonal genotyping methods.
    Fernandez CA; Smith C; Yang W; Lorier R; Crews KR; Kornegay N; Hicks JK; Stewart CF; Kawedia JD; Ramsey LB; Liu C; Evans WE; Relling MV; Broeckel U
    Clin Pharmacol Ther; 2012 Sep; 92(3):360-5. PubMed ID: 22871999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic Testing for Analgesic Adverse Effects: Pediatric Case Series.
    Manworren RC; Jeffries L; Pantaleao A; Seip R; Zempsky WT; Ruaño G
    Clin J Pain; 2016 Feb; 32(2):109-15. PubMed ID: 25803758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing.
    Ly RC; Shugg T; Ratcliff R; Osei W; Lynnes TC; Pratt VM; Schneider BP; Radovich M; Bray SM; Salisbury BA; Parikh B; Sahinalp SC; Numanagić I; Skaar TC
    J Mol Diagn; 2022 Jun; 24(6):576-585. PubMed ID: 35452844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.